| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.083 | 0.6 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.082 | 0.6 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.7 |